Stephen Kanes
AstraZeneca
3
0
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Brendan Smyth
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
Darren Wilbraham
Quintiles Drug Research Unit at Guy's HospitalQuintiles Ltd6 Newcomen StreetLondonSE1 1YRUnited Kingdom
Shared therapeutic areas:
Worked with same sponsors:
Johan Wemer
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
Wolfgang Kühn
Quintiles AB Phase I Services
Shared therapeutic areas:
Worked with same sponsors:
Sigridur Kalman
Karolinska University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Robert B Innis, M.D.
National Institute of Mental Health (NIMH)
Shared therapeutic areas:
Anissa MEGZARI
Centre Hospitalier Universitaire de Nīmes
Shared therapeutic areas:
emilie garrido pradalie
APHM
Shared therapeutic areas:
Waqar ahmed awan, Phd
Riphah International University
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043
Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers
Phase I, Single Centre, Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043
All 3 trials loaded